Similarly, administration of inhibitory monoclonal antibodies against human recombinant ADAMTS13, target antigen in TTP, resulted in reduced ADAMTS13 activity, severe thrombocytopenia and hemolytic anemia in baboons. Here, ADAMTS13 is linked to Thrombocytopenia.